content

HCATS, Apceth Expand Manufacturing Pact with Bluebird Bio

Hitachi Chemical Advanced Therapeutics Solutions, LLC (HCATS) and apceth Biopharma GmbH (apceth), have expanded their relationship with bluebird bio with long-term development and manufacturing...

Thermo Fisher Scientific Announces SARS-CoV-2 GlobalAccess Sequencing Program

To accelerate national, multi-institutional efforts focused on mapping coronavirus transmission and epidemiological studies, Thermo Fisher Scientific announces the SARS-CoV-2 GlobalAccess Sequencing Program for research...

Regeneron and Colorado Center for Personalized Medicine Announce Major New Human Genetics Research Collaboration

Regeneron Pharmaceuticals, Inc. and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus announced a large-scale research collaboration...

Sterling Pharma Solutions commence the production of potential COVID-19 treatment

Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has commenced production of hydroxychloroquine (HCQ), a treatment currently under investigation for COVID-19. Sterling will...

FDA Approves Eli Lilly Precision Oncology Treatment for Certain Lung and Thyroid Cancers

Eli Lilly is moving quickly to get a newly-approved precision oncology treatment for certain lung and thyroid cancers into the hands of patients. Following U.S....

Abbott Earns Emergency Use Authorization for Another COVID-19 Antibody Test

Abbott Laboratories has won Emergency Use Authorization for another COVID-19-related diagnostics test for antibodies. This morning, the company said the U.S. Food and Drug...

Enhertu granted Breakthrough Therapy Designation in the US for HER2-positive metastatic gastric cancer

AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo)โ€™s Enhertu (trastuzumab deruxtecan) has been granted Breakthrough Therapy Designation (BTD) in the US for the treatment...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read